patent/IE-46262-B1

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_600db5b93a54999d3db277d10725d525
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-20
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate	1977-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	1983-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	IE-46262-B1
titleOfInvention	Morphanthridines
abstract	Compounds of formula I, I wherein R is hydrogen, alkyl (C1-4) or hydroxyalkyl (C2-3), are useful as neuroleptics, sleep promoters, myotonolytics, and anti-depressants.
priorityDate	1976-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11634155 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561306 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393349 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511884 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11492

Total number of triples: 20.